Cheol‐In Kang
Impact in
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria
- Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance
Papers in
-
- Antimicrobial Resistance in Staphylococcus 57
- Epidemiology 94
- Pneumonia and Respiratory Infections 28
- Urinary Tract Infections Management 21
- Co-authors
- Kyong Ran Peck (215 shared papers)Doo Ryeon Chung (208 shared papers)Kang Won Choe (24 shared papers)Myoung‐don Oh (24 shared papers)Hong Bin Kim (22 shared papers)Jae‐Hoon Song (77 shared papers)Sung‐Han Kim (15 shared papers)Kwan Soo Ko (55 shared papers)
- Journals
- European Journal of Clinical Microbiology & Infectious Diseases (21 papers)Diagnostic Microbiology and Infectious Disease (17 papers)Microbial Drug Resistance (12 papers)Antimicrobial Agents and Chemotherapy (11 papers)Journal of Korean Medical Science (11 papers)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Cheol‐In Kang
275 papers receiving 8.2k citations
Cheol‐In Kang's Hit Papers
Peers
Comparison fields: 5 of 151
- Molecular Medicine 2.7k
- Applied Microbiology and Biotechnology 895
- Endocrinology 875
- Clinical Biochemistry 1.1k
- Infectious Diseases 2.0k
Countries citing papers authored by Cheol‐In Kang
This map shows the geographic impact of Cheol‐In Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheol‐In Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheol‐In Kang more than expected).
Fields of papers citing papers by Cheol‐In Kang
This network shows the impact of papers produced by Cheol‐In Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheol‐In Kang. The network helps show where Cheol‐In Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheol‐In Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 280 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome Hit paper breakdown → | 2005 | 555 |
| 2 | 2003 | 470 | |
| 3 | 2012 | 293 | |
| 4 | 2011 | 248 | |
| 5 | 2017 | 228 | |
| 6 | 2004 | 226 | |
| 7 | 2007 | 220 | |
| 8 | 2004 | 157 | |
| 9 | 2018 | 147 | |
| 10 | 2009 | 142 | |
| 11 | 2013 | 139 | |
| 12 | 2003 | 111 | |
| 13 | 2011 | 109 | |
| 14 | 2011 | 107 | |
| 15 | 2016 | 104 | |
| 16 | 2006 | 102 | |
| 17 | 2004 | 99 | |
| 18 | 2011 | 90 | |
| 19 | 2013 | 88 | |
| 20 | 2018 | 87 |
About Cheol‐In Kang
Cheol‐In Kang is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Clinical Biochemistry and Pharmacology, having authored 280 papers that have together received 8.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (77 papers), Antimicrobial Resistance in Staphylococcus (57 papers), Bacterial Identification and Susceptibility Testing (39 papers), Pneumonia and Respiratory Infections (28 papers), Antibiotics Pharmacokinetics and Efficacy (27 papers), Urinary Tract Infections Management (21 papers), Antibiotic Use and Resistance (19 papers) and Streptococcal Infections and Treatments (15 papers). The work is most often cited by research in Molecular Medicine (2.7k citations), Applied Microbiology and Biotechnology (895 citations), Endocrinology (875 citations), Clinical Biochemistry (1.1k citations) and Infectious Diseases (2.0k citations). Cheol‐In Kang has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Kyong Ran Peck, Doo Ryeon Chung, Kang Won Choe, Myoung‐don Oh, Hong Bin Kim, Jae‐Hoon Song, Sung‐Han Kim, Kwan Soo Ko, Nam Yong Lee and Wan Beom Park. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Diagnostic Microbiology and Infectious Disease, Microbial Drug Resistance, Antimicrobial Agents and Chemotherapy and Journal of Korean Medical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.